2210-72-2 Usage
Uses
Used in Polymer Production:
[(p-isopropylphenoxy)methyl]oxirane is used as a cross-linking agent for enhancing the properties of polymers, such as strength, flexibility, and durability. Its high reactivity allows it to form strong covalent bonds between polymer chains, resulting in improved material performance.
Used in Adhesives Production:
[(p-isopropylphenoxy)methyl]oxirane is used as a curing agent for epoxy resins in the production of adhesives. Its ability to react with epoxy resins creates a strong bond between the adhesive and the substrate, making it suitable for various applications, including automotive, construction, and electronics industries.
Used in Coatings Production:
[(p-isopropylphenoxy)methyl]oxirane is used as a curing agent in the production of coatings, providing excellent adhesion, corrosion resistance, and chemical resistance. Its use in coatings can be found in various industries, such as automotive, aerospace, and marine, where high-performance coatings are required.
Used in Plastics Production:
[(p-isopropylphenoxy)methyl]oxirane is used in the production of various types of plastics, including thermosetting plastics and elastomers. Its cross-linking ability contributes to the development of plastics with improved mechanical properties, thermal stability, and resistance to chemicals.
Used in Chemical Synthesis:
[(p-isopropylphenoxy)methyl]oxirane serves as an intermediate in the synthesis of various chemical compounds, including pharmaceuticals, agrochemicals, and specialty chemicals. Its reactivity allows for the formation of new chemical bonds and the creation of diverse molecular structures.
Safety Considerations:
Due to its toxic and irritant effects on the skin, eyes, and respiratory system, [(p-isopropylphenoxy)methyl]oxirane should be handled and used with caution in industrial and laboratory settings. Proper safety measures, such as wearing protective gear and ensuring proper ventilation, should be implemented to minimize exposure and potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 2210-72-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,1 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2210-72:
(6*2)+(5*2)+(4*1)+(3*0)+(2*7)+(1*2)=42
42 % 10 = 2
So 2210-72-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H16O2/c1-9(2)10-3-5-11(6-4-10)13-7-12-8-14-12/h3-6,9,12H,7-8H2,1-2H3
2210-72-2Relevant academic research and scientific papers
Regioselective ring-opening of epoxides by carbazole: A direct preparation of novel N-(β-hydroxyalkyl)carbazoles
Soltani Rad, Mohammad Navid,Behrouz, Somayeh,Ahrari, Samira
, p. 137 - 140 (2016/04/20)
The influence of various parameters including solvent, base and temperature on the reaction between carbazole and epoxides was studied This led to the development of a regioselective ring-opening of epoxides by the potassium salt of carbazole in DMSO at 100 °C which is a straightforward way to prepare new N-(β-hydroxyalkyl)carbazoles in good to excellent yields. Fifteen new compounds are described.
SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF
-
Page/Page column 34, (2010/04/23)
The present invention relates to a series of substituted dihydro and tetrahydro oxazolopyrimidinones, specifically, to a series of 2-substituted-2,3-dihydro-oxazolo[3,2-a]pyrimidin-7-ones and 2-substituted-2,3,5,6-tetra-hydro-oxazolo[3,2-a]pyrimidin-7-ones of formula (I): Wherein p, n, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
